Emcure expands injectables capacity, opens 3rd facility in Gujarat
时间:2024-06-26 14:51:43 阅读(143)
The third injectable facility of Emcure Pharmaceuticals in Mehsana, Gujarat, which was commissioned in August 2023, is now ready for commercial supplies to domestic and international markets. The company already has an oral formulations manufacturing line in Mehsana.
It also has a facility in Hinjawadi, Pune, with a capacity of 80.64 million vials per annum and another in Sanand, Gujarat, with a capacity to churn out 72 million vials per annum.
IPO-bound Emcure’s manufacturing operations cover oral solids, oral liquids and injectables, including liposomal and lyophilized injectables, biotherapeutics and complex APIs. The company’s subsidiary Gennova Biopharmaceuticals,also plans to use its mRNA platform, through which it launched the Covid-19 vaccine, forthree other vaccines for Zoster, Zika and Rabies.
Emcure’s injectable portfolio includes complex iron injectables, oncology, steroids, suspensions and emulsions. Emcure can produce high-potency injectables, particularly oncology products.
Emcure had filed a draft red herring prospectus (DRHP) on December 16 for its Rs 800 crore IPO. It is the 12th largest Indian pharmaceutical company and the largest pharmaceutical company in the gynaecology, blood-related and HIV antiviral therapeutics segment in the country.
For the international markets, the firm’s focus is on developing and commercialising products, which requires significant expertise and is subject to less competition and offers higher margins.
In Europe and other key target markets, they are focused on higher-value-added generics and complex injectables, such as Cidofovir and Meropenem. Europe is one of the focus areas in the hospital segment, as it is a large market for complex injectables products, such as Cidofovir, BiCNU and Treprostinil, the company’s DRHP said.
The company is working on `ready-to-use’ products that reduce multi-step dose preparation and enable ease of use by physicians.
上一篇:Across the aisle by P Chidambaram- Shutting out debate in talking shop
下一篇:Will Sensex, Nifty rebound or continue their downward move- 5 things to know before opening bell
猜你喜欢
- This DNA test can detect 18 different early-stage cancers; Here’s what you need to know
- This Rakesh Jhunjhunwala portfolio stock may rally up to 32%, brokerages say buy; check target price
- 5 money-management insights to adopt from Indian business tycoons like Mukesh Ambani, Ratan Tata, Falguni Nayar, and more
- Natural gas consumption down 6%- Energy mission 2030 running out of gas
- The year ahead 2024- Valuations could see downgrades; Funding chill for startups may linger on in new year
- Mumbai Trans Harbour Link- Maharashtra CM Eknath Shinde inspects bridge before inauguration by PM Modi on January 12 – Watch Video
- Tech trends in the healthtech industry to look out for in 2024
- Most in-demand courses in Ireland for international students
- Mumbai Trans Harbour Sealink project- RTI reply reveals project’s cost went up by Rs 2000 crore after missing multiple deadlines